Adjuvant Docetaxel for Node-Positive Breast Cancer

To the Editor: The study by Martin et al. (June 2 issue) 1 raises concern about the high rates of febrile neutropenia among patients receiving a regimen of docetaxel plus doxorubicin and cyclophosphamide (TAC). Moreover, it is not clear that the right comparator is a regimen of fluorouracil plus dox...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The New England journal of medicine 2005-09, Vol.353 (9), p.954-955
Hauptverfasser:	Ahluwalia, Manmeet S, Daw, Hamed A
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Combined Chemotherapy Protocols - administration & dosage Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Breast Neoplasms - drug therapy Breast Neoplasms - mortality Chemotherapy, Adjuvant - adverse effects Cyclophosphamide - administration & dosage Cyclophosphamide - adverse effects Dose-Response Relationship, Drug Doxorubicin - administration & dosage Doxorubicin - adverse effects Fluorouracil - administration & dosage Fluorouracil - adverse effects Humans Lymphatic Metastasis Neutropenia - chemically induced Sepsis - chemically induced Taxoids - administration & dosage Taxoids - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!